Citation Impact
Citing Papers
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
2019
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Actual status of antiinterleukin-1 therapies in rheumatic diseases
2010
Functional Specialization of Interleukin-17 Family Members
2011 Standout
Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence
2007
Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes
2018
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
GLP-1 receptor agonists: an updated review of head-to-head clinical studies
2021
TNF‐mediated inflammatory disease
2007 Standout
Works of Alan Martin being referenced
A randomized, multi-center, blinded, placebo-controlled study with an open-label run-in period to evaluate anakinra in polyarticular-course juvenile rheumatoid arthritis
2006
Self-reported Barriers to Adherence and Persistence to Treatment With Injectable Medications for Type 2 Diabetes
2016
Non-Persistence and Non-Adherence of Patients with Type 2 Diabetes Mellitus in Therapy with GLP-1 Receptor Agonists: A Retrospective Analysis
2015
Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study
2008